Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 4/20 | 0.47 |
| ▸ | EGFR | P00533 | 1/20 | 0.47 |
| ▸ | ULK1 | O75385 | 1/20 | 0.44 |
| ▸ | KDR | P35968 | 1/20 | 0.43 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.43 |
| ▸ | FLT3 | P36888 | 3/20 | 0.43 |
| ▸ | BTK | Q06187 | 2/20 | 0.43 |
| ▸ | PTK2 | Q05397 | 8/20 | 0.43 |
| ▸ | PTK2B | Q14289 | 4/20 | 0.43 |
| ▸ | ALK | Q9UM73 | 2/20 | 0.42 |
| ▸ | WEE1 | P30291 | 1/20 | 0.42 |
| ▸ | CDK1 | P06493 | 2/20 | 0.42 |
| ▸ | CDK4 | P11802 | 1/20 | 0.42 |
| ▸ | CDK2 | P24941 | 1/20 | 0.42 |
| ▸ | AURKA | O14965 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30833721 | 0.91 | BRD4 (0.42) | BRD4EGFRULK1KDRAURKB | |
| SCHEMBL30833633 | 0.87 | EGFR (0.47) | BRD4EGFRULK1KDRAURKB | |
| SCHEMBL29190702 | 0.87 | ALK (0.53) | BRD4EGFRULK1FLT3PTK2 | |
| SCHEMBL30833702 | 0.81 | PTK2 (0.46) | BRD4ULK1PTK2PTK2BCDK1 | |
| SCHEMBL30833672 | 0.81 | ALK (0.51) | BRD4EGFRULK1AURKBPTK2 | |
| SCHEMBL30833801 | 0.79 | EGFR (0.42) | BRD4EGFRULK1KDRAURKB | |
| SCHEMBL29190646 | 0.78 | ALK (0.47) | BRD4EGFRULK1FLT3PTK2 | |
| SCHEMBL30833667 | 0.77 | KDR (0.48) | ULK1KDRAURKBFLT3PTK2 | |
| SCHEMBL29190605 | 0.76 | ALK (0.67) | BRD4EGFRFLT3ALKCDK2 | |
| SCHEMBL30833718 | 0.74 | JAK3 (0.47) | BRD4EGFRKDRAURKBFLT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113896744-B | Selective EGFR inhibitor | 成都先导药物开发股份有限公司 | 2024-04-16 | — | — | CN | disclosed |